PVLA

Palvella Therapeutics
PVLA

Overview Fund Trends Analyst Outlook Journalist POV

75 hedge funds and large institutions have $165M invested in Palvella Therapeutics in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

0.07% more ownership

Funds ownership: 0.53% → 0.6% (+0.07%)

15% less call options, than puts

Call options by funds: $1.59M | Put options by funds: $1.88M

Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.59M
Puts
$1.88M
Net Calls
Net Calls Change

Top Buyers

1
+$7.76M
2
+$6.04M
3
+$5.76M
4
MWNA
Marshall Wace North America
New York
+$4.51M
5
SCM
Soleus Capital Management
Connecticut
+$3.83M

Top Sellers

1
-$4.68M
2
-$3.83M
3
-$2.64M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$982K
5
E
Ergoteles
New York
-$796K
Name Holding Trade Value Shares
Change 		Change in
Stake
76
–
77
–
78
–
79
–
80
–
81
–
82
–
83
–
84
–
85
–
86
–
87
–
88
–
89
–
90
–
91
–
92
–
93
–
94
–
95
–
96
–
97
–
1 2 3
4